Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Twist Bioscience Corp
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Biological Products, (No Diagnostic Substances)
Prev close 137.74 · gapped below the open, then crossed back over prior close. High/low 138.21 at 2:15 pm ET, 131.84 at 4:15 am ET.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“Effective April 1, 2025, the Company entered into an amendment to its four-year supply agreement with Twist for the purchase of diverse products including synthetic DNA.”
FILING10-K0001628280-26-012346cik 0001830214disclosed by DNA
“We rely on Illumina as a sole supplier for our next-generation sequencers and associated reagents, Madison Industries ("Madison") as a sole supplier of blood collection tubes, and Twist Bioscience Corporation ("Twist") as a sole supplier of DNA panels.”
FILING10-K0001628280-26-017319cik 0001699031disclosed by GRAL
“We rely on a limited number of suppliers, including Illumina, Inc., Life Technologies Corporation, Twist Biosciences Corporation, Path-Tec LLC and Agilent Technologies.”
FILING10-K0001818331-26-000015cik 0001818331disclosed by WGS
“On May 2, 2025, the Company executed the Contribution Agreement with Atlas for the sale and transfer of its DNA digital data storage assets including the related intellectual property, equipment and contracts and the license of certain other intellectual property and the license of certain other intellectual property for a consideration of 73.0 million shares of Series Seed-1 Preferred Shares of Atlas, upfront cash consideration of $2.5 million, promissory notes of $2.0 million issued by Atlas, contingent manufacturing and commercial milestone payments of up to $75.0 million, and royalty payments based on a percentage of Atlas sales of the DNA data storage products (see note 6 of the consolidated financial statements included elsewhere in this Form 10-K).”
FILING10-K0001581280-25-000025cik 0001581280
“Under our discovery agreement with Twist, Twist will utilize its proprietary platform technology to assist us with the discovery of novel antibodies related to our gamma delta T cell therapy programs.”
FILING10-K0001720580-26-000008cik 0001720580disclosed by ACET
“We outsource certain functions and supplies to third parties such as Lonza Sales AG, and Twist Bioscience Corporation.”
FILING10-K0001558370-25-011888cik 0001420720disclosed by IBIO
“Some of our partners include Bayer, Boehringer Ingelheim GmbH, Takeda Pharmaceutical Company Limited, Adicet Bio, Ono Pharmaceutical Ltd., Kyowa Kirin, Invetx, Inc., Astellas Pharma Inc. and Neogene Therapeutics, Inc.”
FILING10-K0001581280-25-000025cik 0001581280
“Some of our partners include Bayer, Boehringer Ingelheim GmbH, Takeda Pharmaceutical Company Limited, Adicet Bio, Ono Pharmaceutical Ltd., Kyowa Kirin, Invetx, Inc., Astellas Pharma Inc. and Neogene Therapeutics, Inc.”
FILING10-K0001581280-25-000025cik 0001581280
“Some of our partners include Bayer, Boehringer Ingelheim GmbH, Takeda Pharmaceutical Company Limited, Adicet Bio, Ono Pharmaceutical Ltd., Kyowa Kirin, Invetx, Inc., Astellas Pharma Inc. and Neogene Therapeutics, Inc.”
FILING10-K0001581280-25-000025cik 0001581280
“Some of our partners include Bayer, Boehringer Ingelheim GmbH, Takeda Pharmaceutical Company Limited, Adicet Bio, Ono Pharmaceutical Ltd., Kyowa Kirin, Invetx, Inc., Astellas Pharma Inc. and Neogene Therapeutics, Inc.”
FILING10-K0001581280-25-000025cik 0001581280
“Some of our partners include Bayer, Boehringer Ingelheim GmbH, Takeda Pharmaceutical Company Limited, Adicet Bio, Ono Pharmaceutical Ltd., Kyowa Kirin, Invetx, Inc., Astellas Pharma Inc. and Neogene Therapeutics, Inc.”
FILING10-K0001581280-25-000025cik 0001581280
“Some of our partners include Bayer, Boehringer Ingelheim GmbH, Takeda Pharmaceutical Company Limited, Adicet Bio, Ono Pharmaceutical Ltd., Kyowa Kirin, Invetx, Inc., Astellas Pharma Inc. and Neogene Therapeutics, Inc.”
FILING10-K0001581280-25-000025cik 0001581280
“Some of our partners include Bayer, Boehringer Ingelheim GmbH, Takeda Pharmaceutical Company Limited, Adicet Bio, Ono Pharmaceutical Ltd., Kyowa Kirin, Invetx, Inc., Astellas Pharma Inc. and Neogene Therapeutics, Inc.”
FILING10-K0001581280-25-000025cik 0001581280
“Some of our partners include Bayer, Boehringer Ingelheim GmbH, Takeda Pharmaceutical Company Limited, Adicet Bio, Ono Pharmaceutical Ltd., Kyowa Kirin, Invetx, Inc., Astellas Pharma Inc. and Neogene Therapeutics, Inc.”
FILING10-K0001581280-25-000025cik 0001581280
“Under the Royalty Purchase Agreement, XOMA Royalty provided Twist Bioscience an upfront payment of $15.0 million in cash in exchange for the right to receive half of the future potential milestone and royalty payments resulting from certain antibody discovery and biopharma services agreements between the Company and its customers (see note 17 of the consolidated financial statements included elsewhere in this Form 10-K).”
FILING10-K0001581280-25-000025cik 0001581280
Watchlist prices, news filtered to it, and its next report on your desk.
Twist Bioscience Corp has 0 disclosed suppliers and 15 disclosed customers. Each one is named in an SEC filing, either Twist Bioscience Corp’s own annual report or the counterparty’s, and carries the sentence that discloses it.
No filing we have read names a supplier of Twist Bioscience Corp. Suppliers appear here when Twist Bioscience Corp names them in its own annual report, or when a company names Twist Bioscience Corp as a customer in theirs.
TWST (Twist Bioscience Corp) has 0 disclosed suppliers and 15 disclosed customers, strongest disclosure first.
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move, and a bundle sits past the rings until you open it. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: ACET −15.62%, in the health bundle.